*** Proof of Product ***
Exploring the Essential Features of “Alicia Elam – JNC8 – Is it Still Great? Hypertension Treatment Guidelines”
Speaker: Alicia Elam, PharmD
Duration: 1 Hour 07 Minutes
Format: Audio and Video
Copyright: Mar 02, 2023
Media Type: Digital Seminar
Description
It’s been almost ten years since the JNC8 Guidelines for Hypertension were released, yet some clinicians are not up to date with their evidence-based guidelines for managing patients with hypertension. If you are still prescribing a beta blocker or non-dihydropyridine CCB as a primary antihypertensive…or, if you are recommending an ACE inhibitor for a person of African descent as primary therapy for hypertension with no known kidney disease…then this presentation is for you! Learn the top four initial recommendations for the treatment of hypertension and be prepared to confidently manage ALL of your patients with hypertension.
Speaker
Alicia Elam, PharmD, is a pharmacist and tenured associate professor of pharmacology at Augusta University’s College of Allied Health Sciences. Not only does she oversee admissions for the physician assistant program and relish mentoring students interested in advanced degrees in medicine, pharmacy, and allied health services, but she also directs pharmacology courses for PA students and consults for various academic programs, including nursing. Dr. Elam is responsible for keen insights and guideline updates for opioid prescribing. With over 28 years of pharmacology experience, her expertise is further underscored by her services as a Lieutenant and Medical Services Corps Pharmacy Officer in the US Navy.
Speaker Disclosures:
Financial: Alicia Elam has an employment relationship with Augusta University. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Alicia Elam is a member of the Georgia Pharmacist Association, the Physician Assistant Education Association, National Pharmaceutical Association, and the Georgia Association of Physician Assistants.
Objectives
- Determine what BP treatment should be initiated to improve outcomes according to JNC8.
- Determine the target BP for those undergoing treatment according to JNC8.
- Distinguish the classes of medications that are best to initiate for the treatment of HTN according to JNC8.
Outline
- Joint National Committee Guidelines (JNC8)
- Guideline Emphasis
- Three Questions
- Blood Pressure Goals
- Why is JNC8 more lenient with BP control?
- HDFP
- HSP
- ANBPindefinitely
- VA Cooperative
- Which Antihypertensive Classes are first line?
- What are 2nd, 3rd and later line options for the treatment of HTN?
- What do Trials Matter?
- ALLHAT
- AASK
- What are exceptions to the JNC8 rule?
- Describe follow-up with JNC8
- Discuss Lifestyle changes
- How does JNC8 compare to ACC/AHA 2017 and other guidelines?
Target Audience
- Nurses
- Nurse Practitioner
- Physician Assistant
- Physicians
Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/
